REQUEST A DEMO
Total
USD $0.00
Search more companies

Bs Biotechna S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Manufacturing | Scientific Research and Development Services
Full name: Bs Biotechna S.A. Profile Updated: November 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

BS Biotechna is a biotechnology company. The company develops targeted therapies based on nanotechnology, with a focus on cancer treatment. Their core technology involves designing and manufacturing drug delivery systems capable of transporting two different molecules for synergistic therapeutic benefits. They are also working on nanoparticle-RNA based drugs for anti-cancer therapy and gene therapy for solid tumor patients. The company's delivery platform has been confirmed as an efficient method for stabilizing and delivering functional nucleic acids.

Headquarters
Ul. Szlak 77/222
Krakow; Malopolskie; Postal Code: 31-153

Contact Details: Purchase the Bs Biotechna S.A. report to view the information.

Website: http://bsbiotechna.com

Basic Information
Total Employees:
Purchase the Bs Biotechna S.A. report to view the information.
Outstanding Shares:
Purchase the Bs Biotechna S.A. report to view the information.
Registered Capital:
Purchase the Bs Biotechna S.A. report to view the information.
Incorporation Date:
November 16, 2022
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Bs Biotechna S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-8.26%
Operating profit (EBIT)
-150.07%
EBITDA
-161.98%
Net Profit (Loss) for the Period
-157.51%
Total assets
10.66%
Total equity
-26.81%
Return on Equity (ROE)
-74.52%
Debt to Equity Ratio
-2.92%
Quick Ratio
-1.06%
Cash Ratio
-0.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?